Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/16/2019 - 04/09/2022

Members can access this product for only $25. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

With poor remission rates and unpredictable antidepressant response, identification of treatment response markers can have a significant impact on the personalized care of depression. The Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) trial seeks to improve upon the existing limitations of antidepressant treatment selection and optimization. This session will review the premise of the EMBARC trial, discuss results thus far, and provide participants with an understanding of the future of personalized medicine in the treatment of depression.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Discuss the “markers” and “moderators” selected for the Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) trial and how these may impact treatment response.
  2. Summarize initial findings of the EMBARC trial and the impact these data have on clinical care.
  3. Describe the role of biosignatures, such as the Depression Treatment Response Index, in the personalized care of depression.
  4. Review ongoing and future research related to the EMBARC trial.

Continuing Education Credit and Disclosures

Activity Dates: 05/16/2019 - 04/09/2022
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-19-023-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.